A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady Davis Institute at the Jewish General Hospital, has concluded that the use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease.
from Dementia Big http://ift.tt/2kt4hM0 via alcoholic dementia
http://ift.tt/2jFZLsL
No comments:
Post a Comment